ArticleBMC pulmonary medicine2022

ANK2 as a novel predictive biomarker for immune checkpoint inhibitors and its correlation with antitumor immunity in lung adenocarcinoma.

Wengang Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.